Saniona Icon blue



quote mark

Epilepsy is one of the most common and disabling chronic neurological disorders and currently affects more than 50 million people worldwide, including 3.4 million in the US and 3.2 million people in the EU.

sANIONA’S Pipeline

We are pioneers in ion channel research and are advancing multiple potential new medicines through clinical trials.


Our Science

Saniona is a leader in the discovery of highly specific ion channel modulators. We’ve leveraged our expertise and our proprietary methods to design a robust ion channel drug discovery engine and generate a library now consisting of more than 20,000 proprietary molecules targeting various ion channels.